Cost-Effectiveness of Venetoclax-Based Treatment in Treatment-Naïve Fit Patients With CLL Without TP53 Aberrations.
Saved in:
| Title: | Cost-Effectiveness of Venetoclax-Based Treatment in Treatment-Naïve Fit Patients With CLL Without TP53 Aberrations. |
|---|---|
| Authors: | Ehlers LH; Nordic Institute of Health Economics, Aarhus, Denmark., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., van der Klift M; Department of Haematology, Amphia Hospital, Breda, the Netherlands.; Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Jensen MB; Nordic Institute of Health Economics, Aarhus, Denmark.; Department of Economics, Aarhus University, Aarhus, Denmark., Tran HTT; Department of Haematology, Akershus University Hospital, Oslo, Norway., Kater AP; Department of Haematology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Niemann CU; Department of Haematology, Rigshospitalet, Copenhagen, Denmark. |
| Source: | European journal of haematology [Eur J Haematol] 2026 Jun; Vol. 116 (6), pp. 873-882. Date of Electronic Publication: 2026 Feb 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1600-0609 |
|---|---|
| DOI: | 10.1111/ejh.70143 |
